Many fast-growing technology, biotechnology, and early-stage startup companies choose to pay no dividends. Instead, these enterprises reinvest all of their net earnings back into research and development, facility expansions, debt reduction, or strategic corporate acquisitions to maximize long-term capital appreciation rather than distributing immediate cash yields to shareholders.